ARRY-382

CAS No. 1313407-95-2

ARRY-382( ARRY382 )

Catalog No. M28026 CAS No. 1313407-95-2

ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 275 In Stock
10MG 432 In Stock
25MG 660 In Stock
50MG 886 In Stock
100MG 1144 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ARRY-382
  • Note
    Research use only, not for human use.
  • Brief Description
    ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
  • Description
    ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ARRY382
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    PDE10A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1313407-95-2
  • Formula Weight
    564.68
  • Molecular Formula
    C32H36N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cccc(Cn(c2ccc3)nc(C4CC4)c2c3NC(c2cnc3n2ccc(OCCN2CCN(C)CC2)c3)=O)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hamaguchi W, et al. Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors. Chem Pharm Bull (Tokyo). 2014;62(12):1200-1213.
molnova catalog
related products
  • Vimseltinib

    DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).

  • JNJ-28312141 hydroch...

    JNJ-28312141 is a potent, orally active CSF-1 receptor (CSF-1R) kinase inhibitor with IC50 of 0.69 nM.

  • GW2580

    A potent, selective c-Fms (CSF1R) inhibitor that completely inhibits human cFMS kinase in vitro at 60 nM.